Blood-based test shows promise in Parkinson’s Disease: A blood-based test that measures mitochondrial DNA damage to detect high levels, which are associated with a higher risk of Parkinson’s disease, was described in the journal Science Translational Medicine. The test also found elevated damaged DNA levels among people with an LRRK2 mutation, which is linked to greater odds of developing Parkinson’s.
Researchers in Japan may have solved the problem of air bubbles in sweat affecting the performance of microfluidic wearable sensors. A new technology aims to solve the long-standing problem of air bubbles in sweat affecting the performance of microfluidic wearable sensors
Under a newly signed decree, EPA has only eight months to finalize new rules on EtO sterilization standards
In late August 2023, the U.S. Food and Drug Administration (FDA) approved Abrysvo (Respiratory Syncytial Virus Vaccine), the first vaccine approved for use in pregnant individuals to prevent lower respiratory tract disease (LRTD) and severe LRTD caused by respiratory syncytial virus (RSV) in infants from birth through 6-months of age.
Test developed to predict blood cancer risk: A test based on limited sampling of blood samples has been developed to assess risk of developing blood cancers by the Instituto de Investigación Sanitaria del Principado de Asturias, the Wellcome-MRC Cambridge Stem Cell Institute and University of Cambridge Department of Hematology.
FDA issues guidance on remote interactive inspections: The FDA has issued draft guidance explaining how it plans to request and conduct voluntary remote interactive evaluations of drug manufacturing sites and other facilities covered by its bioresearch monitoring program. “When facilities agree to participate in a remote interactive evaluation, FDA expects them to cooperate with the same level of transparency as they would during an FDA inspection,” the FDA wrote, adding that it expects staff “to be available at scheduled times for interviews and other virtual interactions, and we expect the facility to be operational to the extent possible for FDA to evaluate areas and operations of interest.”
Blood-based test can help determine cause of fever: A blood-based test that can detect and distinguish 18 different inflammatory or infectious diseases and determine the underlying cause of childhood fever has been developed by an international team of researchers led by Imperial College London scientists. Researchers worked on the test by looking at the gene expression patterns in the blood in response to different diseases.
Spine-tingling science explains why fright is fun: Health experts discuss the biological reasons why human beings get enjoyment from being scared in settings like horror movies and haunted houses. Fright can stimulate the same centers of the brain as happiness and pleasure, and it is enjoyable because there is no real threat of harm. Fear also triggers the release of stress hormones and neurotransmitters that induce a “fight, flight, or freeze” response, an evolutionary development that helped early humans avoid danger.
New app to help patients with Parkinson’s walk better: The “Walking Tall” app was created to help patients with Parkinson’s disease relearn and improve their ability to walk. The app provides audio guidance and encouragement to walk with a smooth gait.
The blood-based test SeekInCare was found to detect more than 20 cancer types, according to a study of patients with and without cancer that was presented at an oncology conference. Test sensitivity varied by cancer type and stage.